Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

PFIZER INC.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Public

Established: 1849-01-01

Employees: 88K

Market Cap: $163.3B

Website: http://www.pfizer.com

Clinical Trials

Multiple Dose Escalation Study In Medically Stable Subjects With Psoriasis

Phase 1

Completed

Conditions: Psoriasis
Immunomodulation

Interventions: Drug: tofacitinib

First Posted Date: 2012-11-29

Last Posted Date: 2013-02-20

Lead Sponsor: Pfizer

Target Recruit Count: 59

Registration Number: NCT01736696

Locations: 🇺🇸
Pfizer Investigational Site, Little Rock, Arkansas, United States

A Phase 2, Safety, Tolerability, and Efficacy Study of PD 0360324 in Chronic Pulmonary Sarcoidosis

Phase 2

Terminated

Conditions: Pulmonary Sarcoidosis

Interventions: Other: Normal Saline for injection
Biological: PD 0360324

First Posted Date: 2012-11-22

Last Posted Date: 2020-01-06

Lead Sponsor: Pfizer

Target Recruit Count: 1

Registration Number: NCT01732211

Locations: 🇺🇸
Medical Arts Building, Cincinnati, Ohio, United States
🇺🇸
The Barrett Cancer Center at UC Health, Cincinnati, Ohio, United States
🇺🇸
Mount Sinai School Of Medicine/Mount Sinai Medical Center, New York, New York, United States

and more 2 locations

Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery

Phase 2

Completed

Conditions: Reduction of Hypertrophic Skin Scarring

Interventions: Drug: PF-06473871

First Posted Date: 2012-11-21

Last Posted Date: 2016-02-17

Lead Sponsor: Pfizer

Target Recruit Count: 103

Registration Number: NCT01730339

Locations: 🇺🇸
University of California Irvine - Dermatology Research, Irvine, California, United States
🇺🇸
Perimeter Outpatient Surgery Center, Atlanta, Georgia, United States
🇺🇸
Sanctuary Mediacal Center, Boca Raton, Florida, United States

and more 36 locations

A Phase 1 Study To Evaluate The Pharmacokinetics (PK), Safety, And Bioavailability Of A Modified-Release (MR) Formulation Of Tofacitinib In Healthy Volunteers

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: tofacitinib modified-release (MR) formulation

First Posted Date: 2012-11-21

Last Posted Date: 2012-12-24

Lead Sponsor: Pfizer

Target Recruit Count: 20

Registration Number: NCT01731327

Locations: 🇸🇬
Pfizer Investigational Site, Singapore, Singapore

Compare Ceftazidime-Avibactam + Metronidazole vs Meropenem for Hospitalized Adults With Complicated Intra-Abd Infections

Phase 3

Completed

Conditions: Complicated Intra-abdominal Infection

Interventions: Drug: Ceftazidime-avibactam
Drug: Meropenem
Drug: metronidazole

First Posted Date: 2012-11-14

Last Posted Date: 2017-09-06

Lead Sponsor: Pfizer

Target Recruit Count: 486

Registration Number: NCT01726023

Locations: 🇻🇳
Research Site, Hochiminh, Vietnam

A Study To Assess The Safety And Tolerability Of Different Doses Of PF-06444753 And PF-06444752 In Subjects With Allergic Rhinitis

Phase 1

Completed

Conditions: Allergic Rhinitis

Interventions: Biological: IGE-1
Biological: IGE-2
Biological: Saline

First Posted Date: 2012-11-07

Last Posted Date: 2016-07-11

Lead Sponsor: Pfizer

Target Recruit Count: 190

Registration Number: NCT01723254

Locations: 🇨🇦
Diex Research Montreal Inc., Montreal, Quebec, Canada
🇨🇦
Ottawa Allergy Research Corporation, Ottawa, Ontario, Canada
🇨🇦
Diex Research Sherbrooke Inc., Sherbrooke, Quebec, Canada

and more 1 locations

A Study To Determine The Efficacy And Safety Of Tigecycline Compared With Imipenem/Cliastatin to Treat Complicated Intra-Abdominal Infection

Phase 4

Completed

Conditions: Intra-abdominal Infection

Interventions: Drug: Imipenem/cilastatin
Drug: Tigecycline

First Posted Date: 2012-11-04

Last Posted Date: 2018-04-09

Lead Sponsor: Pfizer

Target Recruit Count: 470

Registration Number: NCT01721408

Locations: 🇨🇳
Affiliated Hospital of Guilin Medical University, Guilin, Guangxi, China
🇨🇳
The Third People's Hospital of Hainan Province/department of general surgery, Sanya, Hainan, China
🇨🇳
Jilin Province People's Hospital, Changchun, Jilin, China

and more 44 locations

A Study To Assess The Safety Of PF-05335810 In Hypercholesterolemic Subjects

Phase 1

Completed

Conditions: Hypercholesterolemia

Interventions: Biological: PF-05335810 Dose A
Biological: PF-05335810 Dose B
Biological: PF-05335810 Dose E
Biological: PF-05335810 Dose C
Biological: PF-05335810 Dose D
Biological: Placebo
Biological: PF-04950615
Biological: PF-04950615 Dose A

First Posted Date: 2012-11-02

Last Posted Date: 2018-12-04

Lead Sponsor: Pfizer

Target Recruit Count: 133

Registration Number: NCT01720537

Locations: 🇺🇸
Pfizer Investigational Site, San Antonio, Texas, United States

Study of LGX818 and Cetuximab or LGX818, BYL719, and Cetuximab in BRAF Mutant Metastatic Colorectal Cancer

Phase 2

Completed

Conditions: Colorectal Cancer

Interventions: Drug: LGX818
Drug: Cetuximab
Drug: BYL719

First Posted Date: 2012-11-01

Last Posted Date: 2021-06-23

Lead Sponsor: Pfizer

Target Recruit Count: 156

Registration Number: NCT01719380

Locations: 🇺🇸
UCLA Santa Monica Medical Center & Orthopaedic Hospital, Santa Monica, California, United States
🇨🇦
Princess Margaret Cancer Centre, Toronto, Ontario, Canada
🇳🇱
Erasmus MC, Rotterdam, Zuid-holland, Netherlands

and more 38 locations

Study Evaluating TheSafety And Efficacy Of PF-05212377 Or Placebo In Subjects With Alzheimer's Disease With Existing Neuropsychiatric Symptoms On Donepezil

Phase 2

Terminated

Conditions: Alzheimer's Disease

Interventions: Drug: PF-05212377 (SAM-760)
Other: Placebo

First Posted Date: 2012-10-23

Last Posted Date: 2017-03-20

Lead Sponsor: Pfizer

Target Recruit Count: 186

Registration Number: NCT01712074

Locations: 🇫🇷
Espace Sante 2, La Seyne Sur Mer, France
🇬🇧
Fulbourn Hospital, Cambridge, United Kingdom
🇪🇸
Hospital de Cantoblanco, Madrid, Spain

and more 57 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy